Sánchez-Molina, S.; Figuerola-Bou, E.; Sánchez-Margalet, V.; de la Cruz-Merino, L.; Mora, J.; de Álava Casado, E.; García-Domínguez, D.J.; Hontecillas-Prieto, L.
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers 2022, 14, 5473.
https://doi.org/10.3390/cancers14215473
AMA Style
Sánchez-Molina S, Figuerola-Bou E, Sánchez-Margalet V, de la Cruz-Merino L, Mora J, de Álava Casado E, García-Domínguez DJ, Hontecillas-Prieto L.
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers. 2022; 14(21):5473.
https://doi.org/10.3390/cancers14215473
Chicago/Turabian Style
Sánchez-Molina, Sara, Elisabet Figuerola-Bou, Víctor Sánchez-Margalet, Luis de la Cruz-Merino, Jaume Mora, Enrique de Álava Casado, Daniel José García-Domínguez, and Lourdes Hontecillas-Prieto.
2022. "Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies" Cancers 14, no. 21: 5473.
https://doi.org/10.3390/cancers14215473
APA Style
Sánchez-Molina, S., Figuerola-Bou, E., Sánchez-Margalet, V., de la Cruz-Merino, L., Mora, J., de Álava Casado, E., García-Domínguez, D. J., & Hontecillas-Prieto, L.
(2022). Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers, 14(21), 5473.
https://doi.org/10.3390/cancers14215473